Roivant Sciences (ROIV) Change in Cash (2020 - 2025)
Roivant Sciences (ROIV) posted Change in Cash of -$1.2 billion for Q4 2025, down 85261.7% on a QoQ basis from -$1.4 million in Q3 2025, and up 72.81% year-over-year from -$715.8 million in Q4 2024.
Roivant Sciences (ROIV) Change in Cash (2020 - 2025) Analysis & Trends
Roivant Sciences' Change in Cash history runs 6 years deep, the most recent figure standing at -$1.2 billion for Q4 2025.
- Quarterly Change in Cash rose 72.81% year-over-year to -$1.2 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$7.3 billion (down 78.17% YoY) and the FY2026 annual result came in at -$1.3 billion, up 66.15% from the prior year.
- Change in Cash was -$1.2 billion for Q4 2025 at Roivant Sciences, down from -$1.4 million in the prior quarter.
- Across five years, Change in Cash topped out at $5.0 billion in Q4 2023 and bottomed at -$4.5 billion in Q4 2024.
- A 5-year average of -$506.9 million and a median of -$242.5 million in 2023 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2023 — Change in Cash jumped 1036.84% — and 2024, when it slumped 13748.95%.
- Roivant Sciences' Change in Cash stood at $84.5 million in 2021, then sank by 731.07% to -$533.0 million in 2022, then soared by 1036.84% to $5.0 billion in 2023, then tumbled by 191.1% to -$4.5 billion in 2024, then soared by 72.81% to -$1.2 billion in 2025.
- Business Quant data shows ROIV's Change in Cash at -$1.2 billion in Q4 2025, -$1.4 million in Q3 2025, and -$1.5 billion in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.24 Bn |
| Sep 30, 2025 | -1.45 Mn |
| Jun 30, 2025 | -1.48 Bn |
| Dec 31, 2024 | -4.55 Bn |
| Sep 30, 2024 | -3.66 Bn |
| Jun 30, 2024 | -857.15 Mn |
| Dec 31, 2023 | 4.99 Bn |
| Sep 30, 2023 | -26.46 Mn |
| Jun 30, 2023 | -242.47 Mn |
| Dec 31, 2022 | -533.00 Mn |
| Sep 30, 2022 | -343.82 Mn |
| Jun 30, 2022 | -117.57 Mn |
| Dec 31, 2021 | 84.46 Mn |
| Sep 30, 2021 | 500.75 Mn |
| Jun 30, 2021 | -133.30 Mn |
| Dec 31, 2020 | -483.58 Mn |
| Jun 30, 2020 | 44.32 Mn |